Cargando…
Predictors associated with clinical improvement of SARS-CoV-2 pneumonia
BACKGROUND: There are few agents that have been proven effective for COVID-19. Predicting clinical improvement as well as mortality or severity is very important. OBJECTIVES: This study aimed to investigate the factors associated with the clinical improvement of COVID-19. METHODS: Overall, 74 patien...
Autores principales: | Mitsumura, Takahiro, Okamoto, Tsukasa, Shirai, Tsuyoshi, Iijima, Yuki, Sakakibara, Rie, Honda, Takayuki, Ishizuka, Masahiro, Aiboshi, Junichi, Tateishi, Tomoya, Tamaoka, Meiyo, Shigemitsu, Hidenobu, Arai, Hirokuni, Otomo, Yasuhiro, Tohda, Shuji, Anzai, Tatsuhiko, Takahashi, Kunihiko, Yasuda, Shinsuke, Miyazaki, Yasunari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885694/ https://www.ncbi.nlm.nih.gov/pubmed/33676842 http://dx.doi.org/10.1016/j.jiac.2021.02.012 |
Ejemplares similares
-
MuLBSTA score is a useful tool for predicting COVID-19 disease behavior
por: Iijima, Yuki, et al.
Publicado: (2021) -
COVID-19 Pneumonia Followed by Anti-signal Recognition Particle Antibody-positive Fibrosing Interstitial Lung Disease
por: Tateishi, Tomoya, et al.
Publicado: (2023) -
Successful diagnosis of humidifier lung by individual provocation test to a responsible environment, a case report
por: Murakami, Takumi, et al.
Publicado: (2022) -
Tolerability of sotorasib for KRAS positive lung adenocarcinoma patient with pre-existing interstitial pneumonia; A case report
por: Okada, Kohei, et al.
Publicado: (2023) -
Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases
por: Mitsumura, Takahiro, et al.
Publicado: (2021)